R. Bert Wilkins, JD, MHA, CIP
Regulatory Chair Director, WCG IRB
Biography
R. Bert Wilkins is one of the Regulatory Chair Directors WCG Institutional Review Board (WCG IRB). Bert has been working for IRBs since 2007. In this role, Bert advises the IRB on appropriateness and regulatory aspects of a wide array of research such as FDA regulated studies, Social/Behavioral Health research, International research, Emergency Research, and research involving vulnerable subjects.
Bert earned a BS from University of Washington, a MHA from University of North Carolina at Chapel Hill, and then a JD from Seattle University.
Latest insights by R. Bert
Ethics in Clinical Research
A Review Of The Regulatory Landscape for In Vitro Gametogenesis
Blog Posts
FDA & ICH
Function over Form: Assessing Different Consent Form Formats
Whitepapers
Ethics in Clinical Research
Should Parents Be Allowed to View their Child’s Survey Responses?
Blog Posts
Ethics in Clinical Research
Ethical and Regulatory Considerations in Patient-to-Patient-Referral Recruitment Plans
Whitepapers
Clinical Endpoints
Do You Know Me?: The Subtle Distinction Between “Anonymous” and “De-identified” Data in Clinical Research
Whitepapers